Evotec

Company Overview

Evotec SE is a global life sciences company that operates multiple business units, providing research and development services, safety assessment, and contract testing to pharmaceutical, biotechnology, and industrial clients worldwide. Through its subsidiaries, it supports the entire cycle, from early discovery through nonclinical development, with functionality that includes in vitro toxicology testing, ADME-Tox profiling, safety pharmacology, and contract research.

Evotec SE offers in vitro and in vivo pharmacology, genetic and safety toxicology, ADME/metabolism studies, bioanalytics, and specialized safety assessment services. The offerings enable clients to evaluate cytotoxicity, genotoxicity, metabolic stability, transporter interactions, organ-specific toxicity, immunotoxicity, and other safety endpoints early in the drug development process.

Financial Highlights (FY 2025)

Company's Business Segments

• Discovery & Preclinical Development : This segment comprises drug discovery and preclinical development services and solutions, starting with sourcing novel treatment ideas derived from patient data and continuing with target validation and lead optimization.
• Just – Evotec Biologics : This segment provides services in the areas of antibody molecular optimization, product and process design, single-use disposable, perfusion-based continuous bioprocessing platforms, covering both early-stage and commercial biomanufacturing.